| Autor: |
Liu, Xiaoyou, Shen, Junyi, Yan, Hongyan, Hu, Jianmin, Liao, Guorong, Liu, Ding, Zhou, Song, Zhang, Jie, Liao, Jun, Guo, Zefeng, Li, Yuzhu, Yang, Siqiang, Li, Shichao, Chen, Hua, Guo, Ying, Li, Min, Fan, Lipei, Li, Liuyang, Luo, Peng, Zhao, Ming |
| Předmět: |
|
| Zdroj: |
MedComm; Sep2024, Vol. 5 Issue 9, p1-37, 37p |
| Abstrakt: |
Posttransplantation complications pose a major challenge to the long‐term survival and quality of life of organ transplant recipients. These complications encompass immune‐mediated complications, infectious complications, metabolic complications, and malignancies, with each type influenced by various risk factors and pathological mechanisms. The molecular mechanisms underlying posttransplantation complications involve a complex interplay of immunological, metabolic, and oncogenic processes, including innate and adaptive immune activation, immunosuppressant side effects, and viral reactivation. Here, we provide a comprehensive overview of the clinical features, risk factors, and molecular mechanisms of major posttransplantation complications. We systematically summarize the current understanding of the immunological basis of allograft rejection and graft‐versus‐host disease, the metabolic dysregulation associated with immunosuppressive agents, and the role of oncogenic viruses in posttransplantation malignancies. Furthermore, we discuss potential prevention and intervention strategies based on these mechanistic insights, highlighting the importance of optimizing immunosuppressive regimens, enhancing infection prophylaxis, and implementing targeted therapies. We also emphasize the need for future research to develop individualized complication control strategies under the guidance of precision medicine, ultimately improving the prognosis and quality of life of transplant recipients. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text